| 1 |
温超超，卢燕鸣. 基于SAT技术分析浦江镇地区儿童肺炎支原体感染的流行病学特点[J/CD]. 中华肺部疾病杂志(电子版), 2020, 13(4): 493-496.
|
| 2 |
Kutty PK, Jain S, Taylor TH, et al. Mycoplasma pneumoniae among children hospitalized with community-acquired pneumonia[J]. Clin Infect Dis, 2019, 68(1): 5-12.
|
| 3 |
Cummiskey AG, Reardon M. Mycoplasma pneumonia: late treatment leading to acute respiratory distress syndrome and renal failure[J]. Eur J Case Rep Intern Med, 2019, 6(2): 1003-1009.
|
| 4 |
Shah SS. Mycoplasma pneumoniae as a cause of community-acquired pneumonia in children[J]. Clin Infect Dis, 2019, 68(1): 13-14.
|
| 5 |
Kumar S, Roy RD, Sethi GR, et al. Mycoplasma pneumoniae infection and asthma in children[J]. Trop Doct, 2019, 49(2): 117-119.
|
| 6 |
Kim AM, Kang S, Park JH, et al. A spatial analysis of geographic variation and factors associated with hospitalization for bacterial pneumonia in Korea[J]. BMC Pulm Med, 2019, 19(1): 45-53.
|
| 7 |
Meyer Sauteur PM, Krautter S, Ambroggio L, et al. Improved diagnostics help to identify clinical features and biomarkers that predict mycoplasma pneumoniae community-acquired pneumonia in children[J]. Clin Infect Dis, 2020, 71(7): 1645-1654.
|
| 8 |
McCurdy S, Keedy K, Lawrence L, et al. Efficacy of delafloxacin versus moxifloxacin against bacterial respiratory pathogens in adults with community-acquired bacterial pneumonia (CABP): microbiology results from the delafloxacin Phase 3 CABP trial[J]. Antimicrob Agents Chemother, 2020, 64(3): 1949-1958.
|
| 9 |
Ma X, Li Y, Liang Y, et al. Development of a DNA microarray assay for rapid detection of fifteen bacterial pathogens in pneumonia[J]. BMC Microbiol, 2020, 20(1): 177-185.
|
| 10 |
葛丽丽，陈重芬，宋银森. 咽拭子支原体RNA检测在儿童肺炎支原体肺炎早期诊断中的应用[J]. 中国卫生检验杂志，2019, 29(24): 3046-3048+3068.
|
| 11 |
Wei F, Jiang Z, Sun H, et al. Induction of PGRN by influenza virus inhibits the antiviral immune responses through downregulation of type I interferons signaling[J]. PLoS Pathog, 2019, 15(10): 321-328.
|
| 12 |
Pogonowska M, Poniatowski A, Wawrzyniak A, et al. The role of progranulin (PGRN) in the modulation of anti-inflammatory response in asthma[J]. Cent Eur J Immunol, 2019, 44(1): 97-101.
|
| 13 |
Qu F, Liu J, Yang AP, et al. Blood procalcitonin and c-reactive protein in distinguishing between bacterial and mycoplasma community-acquired pneumonia in children[J]. J Biol Regul Homeost Agents, 2020, 34(5): 1739-1744.
|
| 14 |
Chen P, Huang Z, Chen L, et al. The relationships between LncRNA NNT-AS1, CRP, PCT and their interactions and the refractory mycoplasma pneumoniae pneumonia in children[J]. Sci Rep, 2021, 11(1): 2059-2066.
|
| 15 |
宋秀明. 专家诊治肺炎[M]. 上海：上海科学技术文献出版社，2012: 112-114.
|
| 16 |
王 娟，李艳红，郭秋野. 胸部X线评分与儿童及成人肺炎支原体肺炎临床表现的相关性研究[J/CD]. 中华肺部疾病杂志(电子版), 2019, 12(3): 352-354.
|
| 17 |
Zhou Y, Wang J, Chen W, et al. Impact of viral coinfection and macrolide-resistant mycoplasma infection in children with refractory Mycoplasma pneumoniae pneumonia[J]. BMC Infect Dis, 2020, 20(1): 633-670.
|
| 18 |
Nakanishi M, Nakashima K, Takeshita M, et al. Ability of high-resolution computed tomography to distinguish Mycoplasma pneumoniae pneumonia from other bacterial pneumonia: Significance of lateral bronchial lesions, less air bronchogram, and no peripheral predominance[J]. Respir Investig, 2020, 58(3): 169-176.
|
| 19 |
Simoni C, Camozzi P, Faré PB, et al. Myositis and acute kidney injury in bacterial atypical pneumonia: Systematic literature review[J]. J Infect Public Health, 2020, 13(12): 2020-2024.
|
| 20 |
Cho YJ, Han MS, Kim WS, et al. Correlation between chest radiographic findings and clinical features in hospitalized children with Mycoplasma pneumoniae pneumonia[J]. PLoS One, 2019, 14(8): 463-468.
|
| 21 |
Ding L, Zhao Y, Li X, et al. Early diagnosis and appropriate respiratory support for Mycoplasma pneumoniae pneumonia associated acute respiratory distress syndrome in young and adult patients: a case series from two centers[J]. BMC Infect Dis, 2020, 20(1): 367-373.
|
| 22 |
Kotela A, Wojdasiewicz P, gosz P, et al. Increased serum levels of progranulin (PGRN) in patients with haemophilic arthropathy[J]. Clin Exp Pharmacol Physiol, 2019, 46(4): 373-379.
|
| 23 |
Luo Q, He X, Zheng Y, et al. Elevated progranulin as a novel biomarker to predict poor prognosis in community-acquired pneumonia[J]. J Infect, 2020, 80(2): 167-173.
|
| 24 |
贝丹丹，程 雁，王宁玲. 颗粒蛋白前体在小儿ARDS和重症肺炎中的价值研究[J]. 中国妇幼健康研究，2019, 37(7): 795-798.
|
| 25 |
Li F, Kong S, Xie K, et al. High ratio of C-reactive protein/procalcitonin predicts Mycoplasma pneumoniae infection among adults hospitalized with community acquired pneumonia[J]. Scand J Clin Lab Invest, 2021, 81(1): 65-71.
|
| 26 |
Neeser OL, Vukajlovic T, Felder L, et al. A high C-reactive protein/ procalcitonin ratio predicts Mycoplasma pneumoniae infection[J]. Clin Chem Lab Med, 2019, 57(10): 1638-1646.
|
| 27 |
Wang J, Mao J, Chen G, et al. Evaluation on blood coagulation and C-reactive protein level among children with mycoplasma pneumoniae pneumonia by different chest imaging findings[J]. Medicine (Baltimore), 2021, 100(3): 239-246.
|
| 28 |
Huang I, Pranata R, Lim MA, et al. C-reactive protein, procalcitonin，D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis[J]. Ther Adv Respir Dis, 2020, 10(1): 98-107.
|
| 29 |
Groeneveld GH, van de Peppel RJ, de Waal MWM, et al. Clinical factors, C-reactive protein point of care test and chest X-ray in patients with pneumonia: A survey in primary care[J]. Eur J Gen Pract, 2019, 25(4): 229-235.
|